B&G Foods, Inc. (BGS) is a New York Stock Exchange-listed packaged foods maker whose portfolio includes shelf-stable and frozen foods, spices, and household products under brands such as Green Giant, Ortega, and Cream of Wheat. Five current, attributable analyst price targets were reviewed. Barclays (Andrew Lazar) carries a $3.00 target as of October 16, 2026; RBC Capital (Nik Modi) stands at $5.00 from October 7, 2026; Jefferies is at $4.00 and Evercore ISI (David Palmer) at $4.50, both from August 12, 2026; and TD Cowen (Robert Moskow) sits at $3.00 with a Sell rating from August 12, 2026. The low-to-high range is $3.00 to $5.00, and the simple average of these five targets is $3.90, rounded to $4.00.
The wide range reflects genuine disagreement. Cautious analysts point to a shrinking revenue base and a heavy debt burden, while more constructive views emphasize leverage reduction and asset sales. Barclays notably cut its target from $4.50 to $3.00 in October 2026, underscoring how quickly sentiment can shift on this name. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock closed near $2.66 in early November 2026, with a 52-week range of roughly $1.99 to $6.38. Reaching the $4.00 central target would require an advance of about 50%, which is best described as a very large move. The path toward such a level would depend on investors re-rating the shares as the company executes its restructuring, rather than on any single quarter. With a market capitalization near $216 million and forward earnings estimates implying a single-digit P/E, the shares are priced for meaningful operational risk.
Management has been aggressively reshaping the portfolio, selling brands such as B&M, Joan of Arc, and the U.S. Green Giant frozen business, while adding higher-margin Collagen and Kitchen Basics brands. Proceeds are intended to reduce leverage ahead of upcoming debt maturities. In the second quarter of 2026, the company grew adjusted EBITDA and reaffirmed full-year guidance despite lower net sales, and it has moved Green Giant U.S. frozen production to a contract manufacturing arrangement. Successful debt reduction and margin stabilization could support a higher valuation. From what I see, monitoring these operational shifts remains key.
The obstacles are substantial. Net sales have been declining, and the company has posted net losses on a trailing basis. The planned sale of the Green Giant Canada business was terminated in October 2026, removing a source of anticipated proceeds. A dividend cut and elevated leverage highlight refinancing risk in a higher-interest-rate environment, while soft consumer demand for packaged foods and competitive pressure add further uncertainty. Valuation compression could persist if the turnaround stalls.
The shares trade far below their 52-week high of about $6.38 but comfortably above the 52-week low near $1.99. The $2.00 level has served as a psychological support zone, while $3.00 represents both a round-number resistance level and the cluster of lower analyst targets. A sustained move above $3.00 would be an important structural signal before any test of the $4.00 target area. I’m watching this closely as part of broader sector analysis.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual analysts may differ. The most important near-term catalyst is the third-quarter 2026 earnings report, released after the market close on November 10, 2026, together with any updated guidance. Investors should also track the pace and terms of remaining divestitures, changes to adjusted EBITDA and leverage, debt refinancing announcements, and any further analyst target revisions.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a volatile turnaround story like B&G Foods (BGS), these signals can help traders identify changing trends, monitor positions, and spot opportunities more efficiently than manual review alone. In my view, exploring these AI-generated signals can add a data-driven layer to your own research process.
The $4.00 central target, derived from five analyst targets averaging $3.90, represents a roughly 50% upside from recent levels near $2.66, making it a very large required move. The bull case rests on successful divestitures, debt reduction, and EBITDA stabilization, while the bear case centers on declining sales, losses, and refinancing risk. With targets ranging from $3.00 to $5.00 and a mix of Hold and Sell ratings, there is no consensus that the shares will reach $4.00. Investors should focus on execution, leverage, and analyst revisions rather than treating the target as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for BGS turned positive on October 29, 2026. Looking at past instances where BGS's MACD turned positive, the stock continued to rise in 37 of 51 cases over the following month. The odds of a continued upward trend are 73%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BGS's RSI Indicator exited the oversold zone, 31 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on BGS as a result. In 62 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
Following a +7.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where BGS advanced for three days, in 167 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
BGS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BGS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.514) is normal, around the industry mean (6.914). P/E Ratio (-2.841) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.300) is also within normal values, averaging (8.458). BGS has a moderately high Dividend Yield (0.152) as compared to the industry average of (0.049). P/S Ratio (0.142) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. BGS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer and a distributor of food products
Industry FoodMajorDiversified